NIPT involves drawing a blood sample from the pregnant woman, usually after the 10th week of pregnancy. The blood sample contains both maternal and fetal cell-free DNA (cfDNA). Advanced sequencing technologies are then used to analyze the cfDNA for chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome).
